NovoCure NVCR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Geography | ||||||
| France | $22.88M+28.1% | $20.29M+29.0% | $19.62M+28.7% | $18.42M+29.1% | $17.86M+70.3% | |
| Germany | $24.5M+30.9% | $21.33M+22.4% | $20.29M+19.4% | $19.07M+26.3% | $18.72M+18.9% | |
| Greater China | $4.8M+3.9% | $4.64M+134% | $5.6M+21.0% | $4.59M-21.5% | $4.62M-6.5% | |
| Japan | $10.24M+17.6% | $10.21M+20.0% | $9.39M+9.4% | $9.48M+23.7% | $8.71M+11.4% | |
| Other international markets | $15.68M+31.3% | $16.28M+56.2% | $15.71M+38.9% | $12.98M+10.3% | $11.94M+33.1% | |
| United States | $95.96M+3.0% | $101.61M-5.2% | $96.61M-1.8% | $94.26M-1.5% | $93.15M+2.9% | |
| Total long lived assets by Geography | ||||||
| Israel | $13.37M-12.9% | $14.06M-12.8% | $49.9M+489% | $49.55M+486% | $15.35M+85.2% | |
| Switzerland | $46.55M-7.8% | $48.13M+78.1% | $14.36M-15.9% | $14.92M+9.6% | $50.51M+362% | |
| United States | $66.34M+3.2% | $65.67M+4.4% | $65.59M+22.5% | $65.58M+30.8% | $64.26M+41.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does NovoCure break its business down?
- NovoCure (NVCR) reports net revenues by geography across 6 parts — France, Germany, Greater China, Japan and Other international markets. Each is extracted from the segment footnotes and tracked over time.
- Where does NovoCure's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in NovoCure's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.